Proximal small intestinal bypass outperforms Roux-en-Y and jejunoileal bypass in glucose regulation in streptozotocin induced diabetic rats.

Although there is an increasing trend for SG in clinical practice, its main role is weight loss, and its efficacy in treating diabetes is not as good as that of RYGB[ 9 ].

also in 63,971 other papers

However, in at least some regions, the proportion of SG among bariatric surgical procedures has been increasing, whereas the implementation of RYGB has remained relatively stable or even shown a decreasing trend[ 7 , 8 ].

also in 47,180 other papers